BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6243403)

  • 41. Marked up-regulation of the beta-bungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists.
    Quik M; Geertsen S; Trifaró JM
    Mol Pharmacol; 1987 Apr; 31(4):385-91. PubMed ID: 3574287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GABAA and GABAB receptors are functionally active in the regulation of catecholamine secretion by bovine chromaffin cells.
    Castro E; Oset-Gasque MJ; González MP
    J Neurosci Res; 1989 Jul; 23(3):290-6. PubMed ID: 2549264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CCCP enhances catecholamine release from the perfused rat adrenal medulla.
    Lim DY; Park HG; Miwa S
    Auton Neurosci; 2006 Jul; 128(1-2):37-47. PubMed ID: 16461015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors.
    Free RB; McKay DB
    Brain Res; 2001 Feb; 891(1-2):176-84. PubMed ID: 11164821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of tramadol on nicotinic acetylcholine receptors in adrenal chromaffin cells and in Xenopus oocytes expressing alpha 7 receptors.
    Shiraishi M; Minami K; Uezono Y; Yanagihara N; Shigematsu A; Shibuya I
    Br J Pharmacol; 2002 May; 136(2):207-16. PubMed ID: 12010769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of substance P on nicotine-induced desensitization of cultured bovine adrenal chromaffin cells: possible receptor subtypes.
    Khalil Z; Marley PD; Livett BG
    Brain Res; 1988 Sep; 459(2):282-8. PubMed ID: 2460186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicotinic receptor-mediated catecholamine secretion from individual chromaffin cells. Chemical evidence for exocytosis.
    Leszczyszyn DJ; Jankowski JA; Viveros OH; Diliberto EJ; Near JA; Wightman RM
    J Biol Chem; 1990 Sep; 265(25):14736-7. PubMed ID: 2394692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-cholinergic component of rat splanchnic nerves predominates at low neuronal activity and is eliminated by naloxone.
    Malhotra RK; Wakade AR
    J Physiol; 1987 Feb; 383():639-52. PubMed ID: 3656137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Participation of GABA/benzodiazepine receptor system in the adrenal chromaffin cell function.
    Guidotti A; Hanbauer I
    Adv Biochem Psychopharmacol; 1986; 42():165-72. PubMed ID: 3020895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of nicotine-induced secretion from bovine chromaffin cells by the amidated C-terminal sequence of the opioid peptide amidorphin.
    Liebisch D; Bommer M; Schimak M; Herz A
    Biochem Biophys Res Commun; 1987 Mar; 143(2):545-51. PubMed ID: 3566736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective inhibition of nicotinic cholinergic receptors by proadrenomedullin N-terminal 12 peptide in bovine adrenal chromaffin cells.
    Kobayashi H; Yamamoto R; Kitamura K; Kuwasako K; Minami S; Yanagita T; Shiraishi S; Yokoo H; Eto T; Wada A
    Brain Res Mol Brain Res; 2001 Mar; 87(2):175-83. PubMed ID: 11245919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the effects of antimitotic drugs on alpha-tubulin mRNA, microtubules and nicotinic receptor-mediated catecholamine secretion in adrenal chromaffin cells in culture.
    Gu H; McKay SB; Burkman AM; McKay DB
    Gen Pharmacol; 1994 May; 25(3):439-46. PubMed ID: 7926588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells.
    Tomé AR; Izaguirre V; Rosário LM; Ceña V; González-García C
    Brain Res; 2001 Jun; 903(1-2):62-5. PubMed ID: 11382388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbachol-induced cosecretion of immunoreactive atrial natriuretic peptides with catecholamines from cultured bovine adrenal medullary cells.
    Okazaki M; Yanagihara N; Izumi F; Nakashima Y; Kuroiwa A
    J Neurochem; 1989 Jan; 52(1):222-8. PubMed ID: 2521183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of the nicotinic alpha-bungarotoxin site in chromaffin cells in culture by a factor(s) endogenous to neuronal tissue.
    Quik M; Fournier S; Trifaró JM
    Brain Res; 1986 Apr; 372(1):11-20. PubMed ID: 3708351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclic AMP and the nicotinic response of bovine adrenal chromaffin cells.
    Dubin AE; Rathouz MM; Mapp KS; Berg DK
    Brain Res; 1992 Jul; 586(2):344-7. PubMed ID: 1381655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Muscarinic receptors in chromaffin cell cultures mediate enhanced phospholipid labeling but not catecholamine secretion.
    Fisher SK; Holz RW; Agranoff BW
    J Neurochem; 1981 Aug; 37(2):491-7. PubMed ID: 7264672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional shift from muscarinic to nicotinic cholinergic receptors involved in inositol trisphosphate and cyclic GMP accumulation during the primary culture of adrenal chromaffin cells.
    Nakaki T; Sasakawa N; Yamamoto S; Kato R
    Biochem J; 1988 Apr; 251(2):397-403. PubMed ID: 2900002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca(2+) and K(+) channels.
    Keating DJ; Rychkov GY; Adams MB; Holgert H; McMillen IC; Roberts ML
    J Physiol; 2004 Mar; 555(Pt 2):489-502. PubMed ID: 14724210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid peptide synthesis in bovine and human adrenal chromaffin cells.
    Wilson SP; Chang KJ; Viveros OH
    Peptides; 1981; 2 Suppl 1():83-8. PubMed ID: 7022398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.